Article Title,Year,Volume,Issue,Page Range,Author
A case report of guardian-consent forced paliperidone palmitate for behavioral disturbance due to traumatic brain injury,2018,8,3,155-158,Douglass
Antiepileptic drugs and suicide-related outcomes in bipolar disorder: a descriptive review of published data,2018,8,3,138-147,Caley
Effectiveness of a direct-to-consumer written health education program in the reduction of benzodiazepine and sedative-hypnotic use in an elderly population at a single Veterans Affairs medical center,2018,8,3,100-104,Erwin
Surveys of substance use disorders education in US pharmacy programs,2018,8,1,14-17,Thomas
Psychiatric symptoms and synthetic cannabinoid use: information for clinicians,2017,7,4,156-159,Martin
Suicide prevention in pharmaceutical education: raising awareness with inspiring stories,2016,6,2,109-113,Vincent
The effects of ketamine on suicidality across various formulations and study settings,2019,9,1,48-60,Lee
Pharmacists' attitudes interest and perceived skills regarding suicide prevention,2019,9,1,30-35,Cates
Public perceptions of naloxone use in the outpatient setting,2019,9,4,275-279,Smith
Traumatic brain injury and mood disorders,2020,10,6,335-345,Robert
Effect of cannabis use on PTSD treatment outcomes in veterans,2021,11,4,238-242,Petersen
Disability and workers' compensation trends for employees with mental disorders and SUDs in the United States,2021,11,5,279-286,Beren
Managing acute agitation and aggression in the world of drug shortages,2021,11,6,334-346,Miller
Consumer perception knowledge and uses of cannabidiol,2023,13,5,217-224,Moeller
A pilot study evaluating the effectiveness of a medicines education group in a mental health inpatient setting: A UK perspective,2017,7,3,116-123,Wright
Approach to the provision of transgender health care in a veteran population,2017,7,4,176-180,Kaigle
Effects of a psychiatric clinical rotation on pharmacy students' attitudes toward mental illness and the provision of pharmaceutical care to the mentally ill,2017,7,5,194-200,Cates
Implementation and evaluation of interprofessional overdose review team recommendations following intentional or accidental overdose events,2024,14,3,224-228,Barrett
The pharmacogenomics of mood stabilizer response in bipolar disorder,2012,1,9,217-221,McCarthy
Recognizing and referring at-risk youth,2013,2,11,353-361,Dopheide
A psychiatric pharmacist in a liver clinic managing treated patients with chronic hepatitis C viral infection,2014,4,6,266-270,Park
A review of the evidence supporting the use of lithium augmentation therapy for the reduction of suicidal behavior in patients with unipolar depression: Revisiting an overlooked benefit of an older medication,2014,4,5,221-225,Jackson
Treatment of depressive symptoms in patients with cancer,2014,4,3,114-117,Schmitt
Antidepressants and suicidality: History the black-box warning consequences and current evidence,2015,5,5,202-211,Noel
A review of suicidality in nonpsychotropic medications,2015,5,5,224-236,Thomas
Analysis of suicide attempts and completions at the South Texas Veterans Health Care System: a retrospective review,2015,5,5,189-196,Oliveira
A review of suicide risk assessment instruments and approaches,2015,5,5,216-223,Cook
Evaluation of a depression case management service: Improving depression care and impact on suicide assessment,2015,5,5,197-201,Hopper
Lithium and clozapine in suicidality: shedding some light to get out of the dark,2015,5,5,237-243,Palmer
Evaluation of provider response to positive depression screenings and physician attitudes on integrating psychiatric pharmacist services in primary care settings,2018,8,1,28-32,Denson
Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion,2018,8,5,250-255,Karst
Donepezil-induced QTc prolongation: A case report,2019,9,3,128-132,Smith
Student pharmacist personal and work experiences with people displaying warning signs of suicidal ideation,2020,10,4,244-249,Witry